Anzeige
Mehr »
Login
Mittwoch, 04.12.2024 Börsentäglich über 12.000 News von 680 internationalen Medien
Analysten eilen, um Kursziele zu verdreifachen nach ATHAs neuester Entdeckung
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

GlobeNewswire (Europe)-Archiv vom 09.11.2024

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
09.11.Corvus Pharmaceuticals, Inc.: Corvus Pharmaceuticals Announces New Data Highlighting Potential of Ciforadenant to Overcome Immunotherapy Resistance in Metastatic Castration Resistant Prostate Cancer92BURLINGAME, Calif., Nov. 09, 2024 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced new data highlighting the potential of...
► Artikel lesen
09.11.Fate Therapeutics, Inc.: Fate Therapeutics Highlights Cancer-selective, HER2-Targeting Profile of FT825 / ONO-8250 CAR T-cell Product Candidate for Treatment of Advanced Solid Tumors at 2024 SITC Annual ...76Novel H2CasMab-2 Antigen Binding Domain Shown to Preferentially Target HER2 Expressed on Tumor Cells in Preclinical Studies Initial Low-Dose Cohort of FT825 / ONO-8250 as Monotherapy Shows Favorable...
► Artikel lesen
09.11.Replimune Group Inc: Replimune Presents Late-Breaking Abstract Featuring Data from IGNYTE Clinical Trial of RP1 Combined with Nivolumab in Anti-PD1 Failed Melanoma at the 39th Annual Meeting of the Society ...52Oral presentation highlighting IGNYTE primary analysis data shows anti-tumor activity across all subgroups with injected and non-injected lesions responding with similar frequency, depth, duration...
► Artikel lesen
09.11.Ultragenyx Pharmaceutical Inc.: Ultragenyx Presents Positive Update on GTX-102 Angelman Syndrome Program at FAST's 17th Annual Global Science Summit37Phase 1/2 data show improvements across all domains and confirm that Phase 3 Aspire study is amply powered to establish efficacy of GTX-102 Phase 3 program on track to begin enrollment by end-of-year...
► Artikel lesen
09.11.GoldHaven Resources Corp.: GoldHaven Completes Acquisition of Copper Peak Metals Inc.465VANCOUVER, British Columbia, Nov. 08, 2024 (GLOBE NEWSWIRE) -- GoldHaven Resources Corp. ("GoldHaven" or the "Company") (CSE: GOH) (OTCQB: GHVNF) (FSE: 4QS0) announces that, further to its news release...
► Artikel lesen
09.11.Nasdaq, Inc.: AppLovin Corporation to Join the Nasdaq-100 Index Beginning November 18, 2024640NEW YORK, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today announced that AppLovin Corporation (Nasdaq: APP), will become a component of the Nasdaq-100 Index® (Nasdaq: NDX®) and the Nasdaq-100...
► Artikel lesen
09.11.Monsha'at: Monsha'at: Biban 2024 accelerates transformation of Saudi entrepreneurship with over SAR 10.6 billion worth of agreements644RIYADH, Saudi Arabia, Nov. 09, 2024 (GLOBE NEWSWIRE) -- The Small and Medium Enterprises General Authority of the Kingdom of Saudi Arabia, Monsha'at, has taken another important step towards reshaping...
► Artikel lesen
09.11.FUJIFILM Europe GmbH: New DeepInsight 'the next stage' by FUJIFILM748Explore the depths of ultrasound for early diagnosis. RATINGEN, Germany, Nov. 09, 2024 (GLOBE NEWSWIRE) -- FUJIFILM Healthcare Europe is proud to launch the next stage of DeepInsight, an innovative...
► Artikel lesen